Cite

HARVARD Citation

    Salaün, H. et al. (2022). Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients. Oncoimmunology. p. . [Online]. 
  
Back to record